Supreme Court Questions Centre on Excluding Most Medicines from Price Control
The Supreme Court questioned the Centre on why most medicines are excluded from the price control regime, emphasizing that economic policy should not override public health. The court reserved its order after hearing arguments, with concerns raised about high drug prices and hospital bills. The Centre defended its calibrated drug-price control approach amid criticism of pharma companies' pricing.
Live Law·

